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Prognosis and Treatment of Asymptomatic Coronary Artery Disease
PETER F. COHN, MD, FACC
Stony Brook, New York
Despite the large number of studies dealing with the
naturalhistory of angiographically definedcoronary ar-
tery disease, there is still a paucity of data on the prog-
nosis of totally asymptomatic persons. From the small
number of reported studies, it appears that prognosis in
selected asymptomatic patients may be better than that
of symptomatic patients. However, the annual mortality
rate in the subgroup ofasymptomatic patients withtriple
vesseldisease was as high as 4 to 5% in some studies
that included patients with prior myocardial infarction
or mild symptoms,or both. This has reinforced theviews
The foundation for a rational plan of therapy in any disease
is a clearunderstandingof the natural history of that disease.
If the natural history ofasymptomaticdisease is not known
and there is little possibility of its being known in the near
future, physicians caring for affected persons have to make
difficult decisionsconcerningtherapy. They first must de-
cide if treating is worse than not treating, and then if they
are to treat, how aggressive that treatment should be. This
review will address theunresolvedissue of treatment for
asymptomatic coronary artery disease after first considering
what is known about the prognosis of patients with this
syndrome(1-6).
Prognosisin AsymptomaticCoronaryArtery
Disease (Table 1)
In coronary artery disease, the most reliable natural his-
tory studies began with the widespread adoption of coronary
arteriographyin the late 1960s. The early arteriographic
studies noted thedifferentprognosis attached to one, two
and three vesseldisease,with the more ominous prognosis
attached to the latter(7). More recent surveys not only
confirm these initialobservations(8), but in many instances
serve as usefulcomparisonsbetween surgically and non-
surgically treated patients(9,10).What has not been clearly
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of those who advocate a more aggressive medical/sur-
gical approach to asymptomatic patients with left main
and triplevesseldisease,especiallyif they have had a
prior infarction. Although several small series of sur-
gically treated patients have been reported to have ex-
cellentshort-term survival rates, the absenceof adequate
con rol groups in nearly all of these studies has left the
issueof prophylactic revascularization unresolved. Until
there is more knowledge of prognosis in patients not
operated on, it is likely to remain unresolved.
d fined in these studies is the effect of lack of anginal
symptoms (chest pain or pressure or its usualeq ivalent)
on prognosis, although some studies havecommentedon
different prognoses attached to more severe types of angina
(11).
Limitingfactorsin definingprognosis.One problem
in defining prognosis in totally asymptomatic patients (as
opposed to those who are asymptomatic after a myocardial
infarction) is the relatively small number of such patients
who undergo coronary arteriography.It is notsurprising
that there is a dearth of such statistics; manyphysiciansare
concerned by the thought of referringasymptomaticpatients
for an invasive procedure with a small, but definite, risk of
morbidity or mortality. Their uneasiness is obviously com-
poundedby the lack of natural history studies. Because the
lattercannotbe obtained at present without angiographic
data, a vicious cycle occurs: the lack of prognostic data in
asymptomatic subjects leads to questionsconcerningthe
need for study in such persons, which in turn ensures that
the number of persons available for prognostic surveys is
small. In the absence of an adequate data baseconcerning
natural history, decisions about therapy are based on an-
ecdotal experiences or are avoided altogether. (The situation
in the postinfarction patient who becomesasymptomaticis
somewhatdifferent, and will be commented on subsequently.)
Availablesurveyson asymptomaticcoronaryartery
disease.Of the few surveys that have providedprognostic
data about asymptomatic coronary arterydis ase,the one
from the U.S. Air Force School of Aerospace Medicine has
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Table1. PrognosisinAsymptomaticPatientsWith AngiographicallyConfirmedCoronaryArteryDisease
No. of Mean Total Cardiac
ReportingInstitutron Patients Follow-up (rna) Events* Mortality
U.S. Air Force, School of 78 36 22(290/c) 3(1% per yr)
AerospaceMedicine(I)
Yale University (2) 12 57 4(33% 0
National Institutes of Health 147 25 27(17%) 8(30/c per yr)
(NIH) (3)
Duke-Harvardr(4) 44 42 13(30%) 4(2.7%per yr)
University ofWashingtont(5) 217 66 NA NA for entire group
GreenLanet(6) 50 54 24(490/c) 5(-2% per yr)
"Angina. myocardial infarction. deathtlncludespatients with pnor myocardial infarction (NIH and University of Washington studies also Included mildly asymptomatic
patients}
NA = not available
providedthe largest seriesofpatients, This study of airmen
with abnormal restelectrocardiogramswas begun by Froe-
licher et al. (12) in the mid 1970s, Cardiaccatheterization
was performedon 138asymptomaticairmen with an ab-
normal treadmill stress test; 30 had significantcoro ary
artery disease.Subsequentreadmillorradionuclidestudies,
or both,performedat thiscenterby Froelicher'sgroup and
then by Hickman and hiscolleagues(I) resulted in a total
of 78 asymptomaticairmen withasymptomaticoronary
artery disease beingdetectedand followed up for prognostic
purposes.The most recentfollow-updata, reported in pre-
liminary form byHickmanet al.(I) showed that 22 of 78
airmen aged 45 to 54 years who had at least 50% luminal
stenosis of one majorcoronaryarterydevelopedovert signs
of coronary artery disease within a 4 to 90 month follow-
up period (mean 57months).Sixteen of the 22developed
angina at a mean of 31.5months,4 sustaineda myocardial
infarction and 2 diedsuddenly.These events occurred at
similar rates inpatientswith one, two and three vessel
disease. Sixothermendevelopedsymptomsat a later time
(mean 46 months); five of the sixdevelopedangina and one
diedsuddenly.On the basis of their data showing that 45%
of the men withsubsequentcardiacevents had three or more
of the standard risk factors forcoronaryartery disease (cig-
arettesmoking,hyperlipidemia,diabetes orhypertension),
the authorsconcludedthat thepresenceof multiple risk
factors stronglyinfluencedthedevelopmentof such events.
Anotherseries of totallyasymptomaticpatients with an-
giographicallyconfirmedcoronaryartery disease, reported
from YaleUniversityby Langouet al. (2), consisted of 12
industrial workers culled from a cohort of 129 subjects by
acombinationof positiveexercisetests andcoronaryartery
calcification on fluoroscopy. Four of the 12 men developed
either angina or amyocardialinfarctionover a 3 year follow-
up period.
Surveyson asymptomaticormildlyasymptomaticpa-
tients.Three other studies havepertinentdata but do not
dealexclusivelywith totallyasymptomaticpopulations.The
larger of the three is from the National Institutes of Health.
In that study (3), 147asymptomaticor mildlyasymptomatic
patients with coronary artery disease were followed up for
6 to 67 months (mean 25).However,only 25of the 147
patients wereasymptomaticand only 5 of the 25 had not
had a prior infarction. These numbers are too small to permit
accurate appraisal by the authors.H wever,by considering
the entire cohorttogether,they did find a lower than ex-
pectedmortalityrate of 3% per year.Mortalityin three
vessel disease was 4% per year. The best clue to the patients
remainingasymptomaticwas theirexercisecapacity,pre-
sumablyreflecting leftventricularfunction. Only 14% of
those who had goodexercisecapacity died or had progres-
sive symptomsover the course of the 7 year follow-up
period.
Theimportanceofleftventricularfunction is further sug-
gested by studies from the UniversityofWashington'sSe-
attle Heart Watch. In a study of 619 patients with minimal
or nosymptoms,Hammermeisteret al. (5), noted only a
2% annual mortality rate in patients with three vessel disease
andejectionfractiongreaterthan 50%. Incontrast,the mor-
tality rate was nearly 5% per year in patients with an ejection
fraction of 31 to 50%. Most patients in the study had a prior
myocardialinfarction,but few hadcongestiveheart failure.
The mortality figures from the twoprecedingstudies are
similar to those reported from theDuk -HarvardCollabo-
rative Coronary Artery Disease Data Bank (4). Here again,
a majority (32) of the 44asymptomaticpatients had a prior
infarction. Of the remaining 12 totallyasymptomaticpa-
tients, nearly all were referred forcor naryangiography
because of a positive exercise test. The mean age of the
group was47.6years; 93% were men, 40% had three vessel
disease, 30% two vessel disease and none had a left main
coronary lesion. Over 70% had an abnormal leftventricular
contraction pattern. Only 3 of the 44 patients were taking
cardiac medications(propranololby 2 andpropranololand
nitrates by I). These three patients wereasymptomaticafter
a myocardial infarction but were givenmedicationfor pro-
phylactic reasons by theirphysicians.When analysis of
prognosis in these 44 patients wasperformed,it was not
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possible toevaluatethe totallyasymptomaticpatients alone
because of the small numbersinvolved.Nevertheless,mor-
tality for the overall group was2.7% per year, a figure
almost identical to thatreportedby the National Institutes
ofHealthinvestigators(3). Again, the subgroup with three
vessel disease had the highest yearly mortality rate, nearly
5% per year ascomparedwith 4% in the National Institutes
of Health study.It should be stressed that unlike patients
in the U.S. Air Force and Yale studies, not all of the patients
in theSeattle,National Institutes of Health and Duke-Har-
vard studies hadevidenceof ongoingmyocardialischemia,
that is, a positiveexercisetest. A positive exercise test
without symptoms isgenerallyregardedas a sign of silent
myocardialischemia(13). Therefore,the prognostic data
obtainedfrom these three studies may not be strictly com-
parable with those of the other two studies cited in which
ongoing ischemiawas demonstratedand the patients had
notsustaineda priormyocardialinfarction.
Epidemiologicstudies.In addition to studies in patients
with angiographicallyconfirmedcoronaryarterydisease,
epidemiologicstudies that utilizeexercisetests in asymp-
tomatic subjects canprovidesome idea of the natural history
of asymptomaticcoronaryartery disease. Forexample,in
anotheraspect of the Seattle Heart Watch Study, Bruce et
al. (14)reportedthat maximal exercise testing identified a
small subgroupof patients who had a sevenfold risk of
having an overtcoronaryartery diseaseevent,with a yearly
mortalityrate of about0.3%. Obviously,not all of the
patients with a positive exercise test have coronary artery
disease (asdiscussedby Uhl andFroelicher[15]earlier in
thisseminar).
Asymptomaticversussymptomaticpatients.If one
assumes that the annual mortality rate forasymptomatic
patients is about 2 to3%, how does thiscomparewith the
rate for patients withsymptomaticdisease?Most studies
report figuresapproximatelytwice as high. Forexample,
theClevelandClinic study (8) reported an annual mortality
rate in its latest 10 yearfollow-upseries of 4% in patients
with one vessel,7% in patients with two vessel and 12.5%
in patients with three vessel disease. In more recent reports
such as that from the Coronary Artery Surgery Study (CASS)
(10),the one, two and three vessel disease annual mortality
rates were 2, 4 and8%, respectively.The multihospital
VeteransAdministrationstudy (9) had figures intermediate
to those reported from the Cleveland Clinic and CASS groups.
In allsubgroupsin all threestudies,prognosiswas affected
adverselyby impaired leftventricularfunction. The Duke-
Harvard Data Bank study is unique in its attempt to evaluate
prognosis in a"comparable"group ofsymptomaticpa-
tients. This was done by using acomputerizedprogram to
"match"the 44asymptomaticpatients in theDuke-Harvard
Data Bank with127symptomaticpatients with similar cor-
onaryanatomy,leftventriculardysfunctionand number of
priormyocardialinfarctions.The yearly mortality rate for
thesymptomaticgroup Was 5.7%, a figureapproximately
twice that of theasymptomaticpatients andconsistentwith
the earlierangiographicstudies cited(8-10),considering
the mix of high risk and low risk patients in this group.
Thus, from these limited studies it would appear that
asymptomaticpatients have a better prognosis than symp-
tomatic patients. The selected nature of these patient pop-
ulations,however,makes theseconclusionstentative.They
do not fully address the larger question ofprognosisthat is
suggested by thephenomenonof asymptomaticoronary
artery disease: because the first overt cardiac event in pa-
ients withcoronaryartery disease is as likely tobesudden
death or a nonfatalmyocardialinfarction as angina, is it
possible thatasymptomaticcoronaryartery disease is pres-
ent in many of these persons for some time before the event?
In other words, does thepopulationwithasymptomaticcoro-
nary artery disease form the pool from which a certain
number of persons will surface each year as victims of
udden death or nonfatal myocardial infarctions? Prelimi-
naryevidencefrom the University of Minnesota suggests
that this may be so.Sharmaet al. (16) studied 19 patients
who were successfullyresuscitatedfrom ventricularfibril-
lation that occurred out of the hospital. All hadangiograph-
ically confirmed multivessel coronary artery disease; II of
the 19 had no prior history of angina or myocardial infarc-
tion. Nearly all the patientsdevelopedpainlesselectrocar-
diographic andangiographicwall motion changes with bi-
cycle exercise. The degree of leftv ntriculardysfunction
was similar inasymptomaticand previouslysymptomatic
patients. The authorsconcludedthat painlessi chemiamay
have a role in the genesis of out of hospitalventricular
fibrillation.
Asymptomaticpostinfarctionpatients.In addition to
data inpopulationsof totallyasymptomaticpersons alone
or mixed withasymptomaticpostinfarctionpatients,there
are also some data focusingexclusivelyon the latter patients.
Because of thewidespreaduse of low level exercise testing
2 to 3 weeks after anu complicatedmyocardialinfarction,
an increasingnumberof patients with silent myocardial
ischemiaare beingdetected.Short-termsurvival statistics
based on thesepostinfarctionexercise tests indicate that
exercise-inducedST segment depression increases consid-
erably the I to2 year mortality rate(17-19).Forexample,
in the studyofTherouxet al.(17) 210patients who had no
overt heart failure and had been free of chest pain for at
least 4 days wereexercisedI day beforedischargefrom the
hospital.The I year mortality rate was 2.1% (3 of 146) in
pati nts without ischemic ST changes during exercise and
27% (17of 64) in those with such changes (probability [p]
< 0.001).The authors noted that" nginain thepresence
of depressionof the ST segment did not increase the prog-
nosticimportanceof depressionof the segment." Thus, 10
of 37 patients with STdepressionbut without angina died
comparedwith 7 of 27 with angina and STdepression.
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Becausethis study was notspecificallydesignedto assess
prognosis in asymptomatic patients, more follow-up is needed
for thatparticulartypeofpatient.The CASS experience(4)
should behelpfulbecauseone of the subsets in that very
large studyconsistsof asymptomaticpostmyocardialin-
farctionpatientsrandomizedto eithermedicalor surgical
therapy,One smallerstudy hasalreadybeenperformedat
Green LaneHospitalin New Zealand(6), One hundred
patientswho were stillpain-free2 months after amyocardial
infarctionwere randomizedto eithermedicalor surgical
therapy,Of the 50 nonsurgicallytreatedpatients,9 devel-
opeddisablinganginaandrequiredsurgery,10 had a non-
fatalreinfarctionarid 5patientsdied.This yields about a
2% yearlymortalityrate for the4'12 year meanfollow-up
period,Prognosiswas worse inpatientswith anejection
fractionof less than 50%,
Treatment of Asymptomatic Coronary
Artery Disease
Becausetheprognosisin totallyasymptomaticcoronary
arterydiseaseis unclear,decisionsconcerningtherapyre-
maincontroversial,expeciallywhen surgeryis considered.
Even thoughthere is still nototallyacceptedconsensusas
to the roleof surgeryin symptomaticoronaryartery dis-
ease,there aregenerallyacceptedguidelinesbasedon a
varietyofrandomizedandnonrandomizedstudies.No such
surgical(or evennonsurgical)guidelinesexist forasymp-
tomaticcoronaryarterydisease,
Medical approach. Certainly,thesimplestapproachis
to 1) modify risk factors when they arepresent,and 2)
reducephysicalactivitieso thatmyocardialischemiadoes
notdevelop.Theoretically,patientswith silentmyocardial
ischemiaand adefectiveanginalwarningsystem may be at
increasedrisk duringstrenuousexertion,Many physicians
would not becontentwithjustthesemeasuresif coronary
arteriographydocumenteda left maincoronarylesion,mul-
tivesseldiseaseor a veryproximalstenosisof the left an-
teriordescendingcoronaryartery.Possibletherapyin such
patientsincludes"prophylactic"administrationofnitrates,
beta-adrenergic blocking agents or calcium antagonists, alone
or incombination.The goalwouldbe toimproveexercise
toleranceby prolongingthe time in which apatientcould
exercisebeforethesilentST segmentdepressiondeveloped.
There is noevidenceatpresenthat suchtherapycan im-
proveprognosisin thesepatients,but one can argue that it
is unlikelythat it can do anyharm.
Indications for surgery. Conti (20) hasoutlinedan ap-
proachfor asymptomaticpatientswithcoronaryartery dis-
ease thatappearsreasonable.If there isevidenceduring
catheterizationfabnormalhemodynamics(such aselevated
leftventricularend-diastolicpressure),abnormallactate me-
tabolismor abnormaleftventricularregional wallmotion,
or both, inadditionto theabnormal exerciseelectrocardio-
gram, Conti would begin therapy asjustdescribed.Aftera
suitableinterval,he would repeat theexercisetest with an
adjunctiveradioisotopicproceduresuch asthallium-20I im-
aging. If the testcontinuesto bemarkedlyabnormal.the
patient is thenconsideredfor surgery.Thus,an aggressive
approachmight entailsurgeryor (now)percutaneoustrans-
luminal coronaryangioplastyif thecoronaryanatomyis
deemedappropriate.As we havenoted,surgeryfor symp-
tomatic disease still hascontroversialaspects;this is even
more true whenasymptomaticdiseaseis considered.Some
investigators(21) areadamantlyagainstit. Othersare in
favor of it in limitedcircumstances,as inselectedpatients
with triple vessel disease ordiseaseofthe left maincoronary
artery (3).
Results of surgery. Coronaryarterybypasssurgeryin
small numbersof asymptomaticpatients(usuallyreported
in mixed series with mildlys mptomaticpatients)has been
performed at several hospitals (Table 2). For example, Grondin
et al. (22) at theMontrealHeartInstitutereportedon the
course of 55surgicallytreatedpatients,19of whom were
totallyasymptomatic.Most of the 55patientshad multi-
vesseldisease.Perioperativemortalitywas zero,but there
were four late deaths and seven lateinfarctionsin the 69
month follow-upperiod,and theauthorsquestionedthe
value of prophylactic revascularization. Pre- and postoper-
ativeexercisetestcomparisonswere notavailable.At the
PeterBentBrighamHospital,20patientswerestudied(23).
Fourteenof the 20 were totallyasymptomaticand 6 were
mildlysymptomatic.Six patientshadsustainedamyocardial
infarction.All but onepatienthad multivesseldisease;four
had left main arterystenosis.Fourteenof 16 preoperative
exercise tests demonstrated silent myocardial ischemia. There
was nopostoperativemortality;one late deathoccurred5
years aftersurgery.Among the!2 patientswith both pre-
andpostoperativeexercisetests, in 8 the testresultreverted
to normal and in 4showeda less ischemicresponseto
exercise.At theClevelandClinic,Thureretal.(24)reported
on 17 patients who wereasymptomaticafter amyocardial
infarction;II had multivesseldisease.Sixteenof the 17
remainedasymptomaticaftersurgery.Thereis no mention
of pre- andpostoperativeexercisetests in thesepatients.
The authors werecautiousin theirconclusions,realizing
that"for properevaluation,surgical results...shouldbe
comparedwith the results ofnonsurgicaltherapyin asimilar
patientgroup."
As we notedearlier,arandomizedtrialofsurgicalversus
nonsurgicalmanagementwas carriedout in NewZealand
in 100patientswho wereasymptomaticafter amyocardial
infarction(6). With a meanfollow-upperiodof 4'12 years,
the annualmortalityrate was the same(about2%) in both
groups.Patientswere notclassifiedaccordingto thenumber
of vessels withdisease,thoughmost patientshad severe
disease.Anotherrelated study (5) wasperformedat the
Universityof Washingtonas partof the previouslycited
ASYMPTOMATIC CORONARY ARTERY DISEASE
Table 2. SurgicalTherapy inAsymptomaticPatientsWithCoronaryArteryDisease*
J AM COLL CARDIOL
1983,1(3)959-64
963
No. of Perioperatrve Mean Late
Reporting Institution PatIents Mortality Follow-up (rno) Mortality
Cleveland Clinic (24) 17 0 75 0
Umversity of Washington (5) 392 15(3.80/0) 65 NA
Peter BentBngham(23) 20 0 34 1(5 % )
Montreal Heart Institute (22) 55 0 69 4(7.30/0 )
Green Lane (6) 50 2(4%) 54 4(8%)
*AII studies Include patients withpnormyocardial mfarcuon Umversuy ofWashington.Peter Bent Brigham and Monlreal HeartInsntutestudies also Includepatrents
with mildsymptom,
NA = notavailable
Seattle HeartWatch.This was anonrandomizedstudy in
which prognosiswas determinedfor medicallyand sur-
gically treatedpatientswho were found to haveg nerally
similarbaselinevariables.In thisseries,114 patients were
asymptomatic and 505 were mildly symptomatic. Both groups
were corribined forlife-tableanalyses.Thesurgicallytreated
patientshad asignificantlylowermortalitythan their med-
icalcounterparts,with thelargestdifferencein survival seen
inpatientswith three vesseldiseaseandmoderatelyimpaired
leftventricularfunction(ejectionfraction 31 to 50%). This
is the onlycomparativestudy,althoughnonrandomized,that
suggests a beneficial effect of surgery onmortalityin asymp-
tomaticpatients.Becauseprognosisin patients with normal
leftventricularfunctionappearsexcellent,the authors noted
that"anenormoussamplesize in arandomizedtherapeutic
trial would berequiredto test thehypothesisthat surgical
therapyimprovessurvivalin thissubgroup,"that is, those
with normal leftventricularfunction. The authorsconcluded
that"prophylacticsurgerymay beindicatedin the asymp-
tomaticor mildy symptomaticpatients withthree-vessel
disease,moderateimpairmentof leftventricularfunction,
good distal vessels and noothermajor medicalillness."
(There were too fewpatientswith left main lesions for the
investigators to make any definite statements about that lesion.)
The forthcomingreportsfrom the CASS registry may
shed further light onprognosisin othersubgroups.Until
thenphysiciansmust weigh theasymptomaticpatient'scor-
onaryanatomyand leftventricularfunction against his or
her age andlifestylein trying todecidewhetheran aggres-
sive approachis indicated.No "firm" guidelinescan be
offeredbeyondthose cited here.Whetherprophylacticre-
vascularizationoffersprotectionagainstsilentmyocardial
ischemiais still anunresolvedissue.
Conclusion
The few naturalhistorystudies that relate to totally
asymptomaticoronaryarterydiseaseshow a low annual
mortalityrate but ahigherincidenceof other cardiac events
(developmentof angina ormyocardialinfarction).This sug-
gests that theasymptomaticstate may be theforerunnerof
theclinicalstate in manypatients.However,in other pa-
tients, such as those with left main or triple vesseldisease,
the firstmanifestationof the clinical state may be sudden
death or amassivemyocardialinfarction,which even if
nonfatalcould beincapacitating;hence, the need for an open
mind towarda moreaggressiveapproach,at least for some
persons.We know that silentmyocardialischemiais oc-
curringin some of thesepersonsat relatively low levels of
exertion;toprotecthemyocardiumby medical or surgical
therapyin suchinstancescertainlyseemsworthwhile.
In patients who areasymptomaticafter amyocardialin-
farction and who stilldemonstratemyocardialischemia,
prognosisdoes seem to be worse than in thosewithoutsuch
ischemia.Here anaggressiveapproach is even morejus-
tifiable, though again, thenecessarycontrolledstudies are
not yetavailable.In the absence of suchstudies,the phy-
sician must use his ownjudgmentandwhateverdata sem-
inars like the present one canprovide.
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